Clinical Trial Update: Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease [Phase 1]

View source ↗

Summary

A Phase 1 positron emission tomography study in Alzheimer's disease sponsored by H. Lundbeck A/S has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Alzheimer's Disease | Phase 1 | Status: TERMINATED